Miranda 2011.
Methods | Randomised placebo‐controlled trial |
Participants | 91 non–treatment‐seeking heavy drinkers; mean age 35.9; 58% male; 19% African American |
Interventions | (1) Topiramate; (2) placebo Drug dose: topiramate up to 200 mg/d Setting: outpatient Duration: five weeks. Country of origin: USA |
Outcomes | Number of drinking days; percentage of heavy drinking days; average number of drinks per drinking day; craving |
Notes | Conference proceedings |